Advertisement

Latest News

Metformin May Lower Cardiac Dysfunction Risk During VEGF Inhibitor Therapy

15 minutes ago

Fadi Haroun, MD, discusses a retrospective analysis linking metformin to lower cardiac dysfunction risk in patients receiving VEGF inhibitors.

Single Annual Injection Produces Significant and Sustained Lp(a) Reductions

1 hour ago

Kausik Ray, MD, MBChB, MPhil, discusses recent results from a trial of the investigational siRNA SRSD216, targeting Lp(a) on a cellular level.

Why CKM Screening Starts With One Patient, With David Van Wyck, MD

3 hours ago

A nephrologist describes how DaVita’s community CKM screenings prepare people before they ever reach a physician.

Building Trust Into Community Kidney Screening, With David Van Wyck, MD

3 hours ago

A nephrologist describes how DaVita’s community CKM screenings prepare people before they ever reach a physician.

Ruvonoflast Reduces hsCRP, Inflammation, CVD Risk With Downstream Effects

4 hours ago

Kausik Ray, MD, MBChB, MPhil, discusses the results from the phase 2 RESOLVE-1 trial, highlighting the investigational treatment’s effects on inflammatory biomarkers.

Advertisement
Advertisement